# Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

> **NCT05728632** · PHASE3 · UNKNOWN · sponsor: **Giulio Stefanini** · enrollment: 80 (actual)

## Conditions studied

- Breast Cancer
- Lymphoma, Large B-Cell, Diffuse
- Cardiotoxicity
- Left Ventricular Dysfunction
- Chemotherapy Effect

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05728632
- **Lead sponsor:** Giulio Stefanini
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05728632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05728632, "Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05728632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*